Skip to main content
Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.030
-0.040 (-1.30%)
At close: Mar 9, 2026, 4:00 PM EDT
3.030
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:00 PM EDT

Evotec SE Revenue

Evotec SE had revenue of 163.89M EUR in the quarter ending September 30, 2025, a decrease of -11.36%. This brings the company's revenue in the last twelve months to 756.33M, down -2.67% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.

Revenue (ttm)
756.33M EUR
Revenue Growth
-2.67%
P/S Ratio
1.25
Revenue / Employee
157,963 EUR
Employees
4,788
Market Cap
1.11B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024796.97M15.54M1.99%
Dec 31, 2023781.43M29.98M3.99%
Dec 31, 2022751.45M133.41M21.59%
Dec 31, 2021618.03M117.11M23.38%
Dec 31, 2020500.92M54.49M12.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.25B
ANI Pharmaceuticals 883.37M
Tilray Brands 837.32M
Collegium Pharmaceutical 780.57M
Pacira BioSciences 726.41M
Amphastar Pharmaceuticals 719.89M
Alvotech 573.35M
Harrow 272.30M
Revenue Rankings

EVO News

More News